tirzepatide heart rate Does Increase Rate? Cardiovascular Effects Tirzepatide for Heart Failure with

Your symptoms should begin to alleviate in a matter of days

The current medications vary in mechanism and magnitude: Semaglutide (Ozempic) targets GLP-1 receptors - around 15% average weight loss Tirzepatide (Mounjaro) targets GLP-1 + GIP - around 20% weight loss, often better GI tolerance Retatrutide (Phase 3 Trials) targets three receptors around 24% weight loss in trials, with broader metabolic effects The real risk is muscle mass loss

Blue Fin Vision Medical Director Mr Mfazo Hove was invited to comment on the findings

The best results are achieved when the medication is combined with healthy lifestyle changes

Water Retention and Swelling: Some users report edema and water retention, particularly in extremities